# Hepatic Artery Infusion Pump Chemotherapy With Floxuridine and Dexamethasone in Combination With Systemic Chemotherapy for Patients With Colorectal Cancer Metastatic to the Liver

> **NCT03366155** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 24 (actual)

## Conditions studied

- Colorectal Cancer
- Liver Metastases
- Colorectal Adenocarcinoma
- Colorectal Cancer With Hepatic Metastases
- Colorectal Carcinoma

## Interventions

- **DEVICE:** Codman 3000 constant flow pump catheter
- **DRUG:** Panitumumab
- **DRUG:** FUDR-Dex
- **DRUG:** Oxaliplatin
- **DRUG:** 5FU
- **DRUG:** Irinotecan
- **PROCEDURE:** HAIP installation
- **DRUG:** cetuximab
- **DEVICE:** Medtronic SynchroMed II Pump

## Key facts

- **NCT ID:** NCT03366155
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-24
- **Primary completion:** 2025-11-13
- **Final completion:** 2025-11-13
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2026-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03366155

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03366155, "Hepatic Artery Infusion Pump Chemotherapy With Floxuridine and Dexamethasone in Combination With Systemic Chemotherapy for Patients With Colorectal Cancer Metastatic to the Liver". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT03366155. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*